Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Current perspectives on the use of ancillary materials for the manufacture of cellular therapies.

Solomon J, Csontos L, Clarke D, Bonyhadi M, Zylberberg C, McNiece I, Kurtzberg J, Bell R, Deans R.

Cytotherapy. 2016 Jan;18(1):1-12. doi: 10.1016/j.jcyt.2015.09.010. Epub 2015 Dec 1.

2.

Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.

Bravery CA, Carmen J, Fong T, Oprea W, Hoogendoorn KH, Woda J, Burger SR, Rowley JA, Bonyhadi ML, Van't Hof W.

Cytotherapy. 2013 Jan;15(1):9-19. doi: 10.1016/j.jcyt.2012.10.008. Review.

PMID:
23260082
3.

A changing time: the International Society for Cellular Therapy embraces its industry members.

Deans R, Gunter KC, Allsopp T, Bonyhadi M, Burger SR, Carpenter M, Clark T, Cox CS, Driscoll D, Field E, Huss R, Lardenoije R, Lodie TA, Mason C, Neubiser R, Rasko JE, Rowley J, Maziarz RT.

Cytotherapy. 2010 Nov;12(7):853-6. doi: 10.3109/14653249.2010.523958.

PMID:
20942603
4.

Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells.

Montcuquet N, Mercier-Letondal P, Perruche S, Duperrier A, Couturier M, Bouchekioua A, Bonyhadi M, Ferrand C, Tiberghien P, Robinet E.

Immunology. 2008 Nov;125(3):320-30. doi: 10.1111/j.1365-2567.2008.02843.x. Epub 2008 Apr 26.

5.

Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.

Mercier-Letondal P, Montcuquet N, Sauce D, Certoux JM, Jeanningros S, Ferrand C, Bonyhadi M, Tiberghien P, Robinet E.

Cytotherapy. 2008;10(3):275-88. doi: 10.1080/14653240801927032.

PMID:
18418773
6.

Transcriptome of retrovirally transduced CD8+ lymphocytes: influence of cell activation, transgene integration, and selection process.

Deschamps M, Robinet E, Certoux JM, Mercier P, Sauce D, De Vos J, Montcuquet N, Bonyhadi M, Rème T, Tiberghien P, Ferrand C.

Mol Immunol. 2008 Feb;45(4):1112-25. Epub 2007 Sep 10.

PMID:
17825913
7.

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF.

Exp Hematol. 2007 Dec;35(12):1823-38. Epub 2007 Aug 30.

8.

Cell isolation and expansion using Dynabeads.

Neurauter AA, Bonyhadi M, Lien E, Nøkleby L, Ruud E, Camacho S, Aarvak T.

Adv Biochem Eng Biotechnol. 2007;106:41-73. Review.

PMID:
17680228
9.

Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality.

van Rijn RS, Simonetti ER, Hagenbeek A, Bonyhadi M, Storm G, Martens AC, Ebeling SB.

Exp Hematol. 2007 Jan;35(1):117-27.

PMID:
17198880
10.

Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversity.

Long SA, Khalili J, Ashe J, Berenson R, Ferrand C, Bonyhadi M.

J Immunol Methods. 2006 Dec 20;317(1-2):100-13. Epub 2006 Oct 17.

PMID:
17081557
11.

Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy.

Onlamoon N, Hudson K, Bryan P, Mayne AE, Bonyhadi M, Berenson R, Sundstrom BJ, Bostik P, Ansari AA, Villinger F.

J Med Primatol. 2006 Aug;35(4-5):178-93.

PMID:
16872281
12.
13.

Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.

Karakhanova S, Munder M, Schneider M, Bonyhadi M, Ho AD, Goerner M.

J Immunother. 2006 May-Jun;29(3):336-49.

PMID:
16699377
14.

Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.

Parmar S, Robinson SN, Komanduri K, St John L, Decker W, Xing D, Yang H, McMannis J, Champlin R, de Lima M, Molldrem J, Rieber A, Bonyhadi M, Berenson R, Shpall EJ.

Cytotherapy. 2006;8(2):149-57.

PMID:
16698688
15.

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.

Trenado A, Sudres M, Tang Q, Maury S, Charlotte F, Grégoire S, Bonyhadi M, Klatzmann D, Salomon BL, Cohen JL.

J Immunol. 2006 Jan 15;176(2):1266-73.

16.

Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.

Bondanza A, Valtolina V, Magnani Z, Ponzoni M, Fleischhauer K, Bonyhadi M, Traversari C, Sanvito F, Toma S, Radrizzani M, La Seta-Catamancio S, Ciceri F, Bordignon C, Bonini C.

Blood. 2006 Mar 1;107(5):1828-36. Epub 2005 Nov 17.

17.

Effect of CD3/CD28 bead-activated and expanded T cells on leukemic B cells in chronic lymphocytic leukemia.

Patten P, Devereux S, Buggins A, Bonyhadi M, Frohlich M, Berenson RJ.

J Immunol. 2005 Jun 1;174(11):6562-3; author reply 6563. No abstract available.

18.

In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.

Earle KE, Tang Q, Zhou X, Liu W, Zhu S, Bonyhadi ML, Bluestone JA.

Clin Immunol. 2005 Apr;115(1):3-9.

PMID:
15870014
19.

Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors.

Noonan K, Matsui W, Serafini P, Carbley R, Tan G, Khalili J, Bonyhadi M, Levitsky H, Whartenby K, Borrello I.

Cancer Res. 2005 Mar 1;65(5):2026-34.

20.

In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.

Bonyhadi M, Frohlich M, Rasmussen A, Ferrand C, Grosmaire L, Robinet E, Leis J, Maziarz RT, Tiberghien P, Berenson RJ.

J Immunol. 2005 Feb 15;174(4):2366-75.

21.

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.

Kalamasz D, Long SA, Taniguchi R, Buckner JH, Berenson RJ, Bonyhadi M.

J Immunother. 2004 Sep-Oct;27(5):405-18.

PMID:
15314550
22.

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA.

J Exp Med. 2004 Jun 7;199(11):1455-65.

23.

Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells.

Coito S, Sauce D, Duperrier A, Certoux JM, Bonyhadi M, Collette A, Kuehlcke K, Hervé P, Tiberghien P, Robinet E, Ferrand C.

Stem Cells Dev. 2004 Feb;13(1):71-81.

PMID:
15068695
24.

IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells.

Skov S, Bonyhadi M, Odum N, Ledbetter JA.

J Immunol. 2000 Apr 1;164(7):3500-5.

25.

Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms.

Kovalev G, Duus K, Wang L, Lee R, Bonyhadi M, Ho D, McCune JM, Kaneshima H, Su L.

J Immunol. 1999 Jun 15;162(12):7555-62.

26.

The SCID-hu mouse: an in vivo model for HIV-1 infection in humans.

Bonyhadi ML, Kaneshima H.

Mol Med Today. 1997 Jun;3(6):246-53. Review.

PMID:
9211415
27.

RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.

Bonyhadi ML, Moss K, Voytovich A, Auten J, Kalfoglou C, Plavec I, Forestell S, Su L, Böhnlein E, Kaneshima H.

J Virol. 1997 Jun;71(6):4707-16.

28.

Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro.

Su L, Lee R, Bonyhadi M, Matsuzaki H, Forestell S, Escaich S, Böhnlein E, Kaneshima H.

Blood. 1997 Apr 1;89(7):2283-90.

29.

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.

Plavec I, Agarwal M, Ho KE, Pineda M, Auten J, Baker J, Matsuzaki H, Escaich S, Bonyhadi M, Böhnlein E.

Gene Ther. 1997 Feb;4(2):128-39.

30.

Identification of HIV-1 determinants for replication in vivo.

Su L, Kaneshima H, Bonyhadi ML, Lee R, Auten J, Wolf A, Du B, Rabin L, Hahn BH, Terwilliger E, Mccune JM.

Virology. 1997 Jan 6;227(1):45-52.

31.

Development of a human thymic organ culture model for the study of HIV pathogenesis.

Bonyhadi ML, Su L, Auten J, McCune JM, Kaneshima H.

AIDS Res Hum Retroviruses. 1995 Sep;11(9):1073-80.

PMID:
8554904
32.

HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo.

Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM.

Immunity. 1995 Jan;2(1):25-36.

33.
34.

Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.

Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J, et al.

J Exp Med. 1993 Oct 1;178(4):1151-63.

35.

HIV induces thymus depletion in vivo.

Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H.

Nature. 1993 Jun 24;363(6431):728-32.

PMID:
8100043
36.

Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication.

Mocarski ES, Bonyhadi M, Salimi S, McCune JM, Kaneshima H.

Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):104-8.

37.

Expression of a fetal gamma delta T-cell receptor in adult mice triggers a non-MHC-linked form of selective depletion.

Iwashima M, Green A, Bonyhadi M, Davis MM, Allison JP, Chien YH.

Int Immunol. 1991 Apr;3(4):385-93.

PMID:
1831656
38.

Gamma delta T cells in murine epithelia: origin, repertoire, and function.

Allison JP, Asarnow DM, Bonyhadi M, Carbone A, Havran WL, Nandi D, Noble J.

Adv Exp Med Biol. 1991;292:63-9. Review.

PMID:
1835264
39.

Limited diversity of gamma delta antigen receptor genes of Thy-1+ dendritic epidermal cells.

Asarnow DM, Kuziel WA, Bonyhadi M, Tigelaar RE, Tucker PW, Allison JP.

Cell. 1988 Dec 2;55(5):837-47.

PMID:
2847872
40.

Gamma delta antigen receptors of Thy-1+ dendritic epidermal cells: implications for thymic differentiation.

Allison JP, Havran WL, Asarnow D, Tigelaar RE, Tucker PW, Bonyhadi M.

Immunol Res. 1988;7(4):292-302. No abstract available.

PMID:
2906352
41.

Delta is the Cx-gene product in the gamma/delta antigen receptor of dendritic epidermal cells.

Bonyhadi M, Weiss A, Tucker PW, Tigelaar RE, Allison JP.

Nature. 1987 Dec 10-16;330(6148):574-6.

PMID:
3500417
42.

Regulation of T-cell receptor gamma-chain RNA expression in murine Thy-1+ dendritic epidermal cells.

Kuziel WA, Takashima A, Bonyhadi M, Bergstresser PR, Allison JP, Tigelaar RE, Tucker PW.

Nature. 1987 Jul 16-22;328(6127):263-6.

PMID:
2885757
43.

Supplemental Content

Loading ...
Support Center